Dacisteine

Dacisteine (N, S-Diacetyl-L-cysteine) is a cysteine derivative and displays a less New Delhi metallo-beta-lactamase-1 (NDM-1) inhibitor with an IC50 value of 1000 μM[1]. Dacisteine can be used for the treatment of cardiovascular and cerebrovascular diseases caused by platelet aggregation[2].

Product Specifications

CAS Number

[18725-37-6]

Product Name Alternative

N, S-Diacetyl-L-cysteine

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Endogenous Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/dacisteine.html

Purity

99.76

Solubility

DMSO : ≥ 250 mg/mL

Smiles

CC(SC[C@@H](C(O)=O)NC(C)=O)=O

Molecular Formula

C7H11NO4S

Molecular Weight

205.24

Precautions

H302, H315, H319, H335

References & Citations

[1]Cui-Gai Bai1, et al. Cysteine and Its Derivatives as New Delhi Metallo-beta-lactamase-1 Inhibitors. Current Enzyme Inhibition, 2015, 11, 46-57|[2]FanKe, et al.Application of compound of thioether acid structure in preparing anti-platelet aggregation drugs. Patent WO2019007015A1.